comparemela.com

Latest Breaking News On - Drug user fee act - Page 9 : comparemela.com

Otsuka and Lundbeck Issue Statement on U.S. Food and Drug Administration (FDA) Advisory Committee Me

The Prescription Drug User Fee Act (PDUFA) target action date is May 10, 2023PRINCETON, N.J. & DEERFIELD, Ill. (BUSINESS WIRE) Otsuka Pharmaceutical Development & Commercialization, Inc., (Otsuka) and Lundbeck Pharmaceuticals LLC (Lundbeck) announce the Joint Meeting of the Psychopharmacologic Drugs Advisory C.

Mansfield
Nunavut
Canada
Italy
Lerdrup
Midtjylland
Denmark
Tokyo
Japan
United-states
California
France

IntelGenx Technologies Corp. (PNK:IGXT) Q4 2022 Earnings Call Transcript

Operator: Greetings and welcome to the IntelGenx Fourth Quarter and Full Year 2022 Financial Results Conference Call. At this time all participants are in listen-only mode.

United-states
Toronto
Ontario
Canada
Spain
Lebanon
New-zealand
Sweden
America
Swedish
Canadian
David-kideckel

Fecal Microbiota Transplant Therapy May Change Paradigm of C. Difficile Treatment

Spherix Global Insights estimates that SER-109 (Seres Therapeutics; Aimmune) will be able to challenge fecal microbiota, live-jslm in C. difficile treatment.

Dynamix-clostridioides
Finch-pharmaceuticals
Ferring-pharmaceuticals
Spherix-global
Seres-therapeutics
Vedanta-biosciences
Drug-user-fee-act
Global-insights

FDA Outlines Next Steps to Weave Digital Health Data Into Clinical Trials

Digital health data can facilitate the participation of underrepresented and diverse patient populations in clinical trials, but first the FDA must build its capability to evaluate such information in its regulatory processes for new drug development.

Drug-user-fee-act
Digital-health-technologies
Remote-data-acquisition
Decentralized-clinical-trials
Biological-products
Regulatory-considerations
Prescription-drug-use-related
Digital-health
Fda
Drug-development

vimarsana © 2020. All Rights Reserved.